Follow Us:
Sunday, January 19, 2020

Prabha Raghavan

Profile

Drug regulator flags 47 medicines for failing quality tests
Fri, Jan 17, 2020

Abbott’s Udiliv, Mankind’s Ferikind-M and Torrent’s Lorvas among flagged.

‘Must run’ status, no power curtailment for renewable energy plants: Expert panel
Wed, Jan 15, 2020

The Indian Electricity Grid Code lays down rules for participants in the power ecosystem to plan, develop, maintain and operate power system, states the draft.

HealthMin plans crowdfunding platform to help treat rare diseases
Tue, Jan 14, 2020

The draft National Policy for Rare Diseases proposes a digital platform for bringing together notified hospitals with such patients and prospective donors.

K Srinath Reddy: ‘The price (of drugs) should not exceed the cost price by an unreasonable amount’
Mon, Jan 06, 2020

Dr Reddy, says that any policy developed by the government should not be knee-jerk, and should focus on ensuring affordability, availability and quality.

After capping trade margins on 42 cancer drugs in 2019, govt may expand move to other medicines
Sun, Jan 05, 2020

The National Pharmaceutical Pricing Authority (NPPA), along with the Department of Pharmaceuticals (DoP), has been finalising a proposal to limit the trade margins of non-scheduled medicines and medical devices, which are not under price control.

Post RCEP walk out, Centre to focus more on bilateral trade agreements in 2020
Tue, Dec 31, 2019

In the words of the Commerce Ministry, Indian industry and services will be competitive and benefit from access to “large developed markets”.

TB antibiotic, acid reflux drug among 37 batches flagged for failing quality tests
Tue, Dec 24, 2019

The regulator this month labelled specific batches of Coxerin as well as Rabium-DSR to be “not of standard quality”.

UDAY scheme loses power, sharp spike in discom losses
Mon, Dec 23, 2019

Discom losses, which had progressively reduced in the first couple of years since the scheme’s rollout in November 2015, have rebounded in FY ’19 to nearly double the losses recorded the previous year.

India Inc silent on CAA protests, Hero’s Naveen Munjal says may hit image
Sat, Dec 21, 2019

Most of the prominent India Inc leaders excused themselves from talking on the ongoing protests. A few who responded to queries said that while people have a right to protest, these mass demonstrations contribute to building a negative image and could hit investment sentiment.

CGHS, ECHS: Hospitals to ‘stop cashless services’ if dues not paid in 30 days
Fri, Dec 20, 2019

Cashless services for the Ex-Servicemen Contributory Health Scheme (ECHS) may also be suspended, he said, adding that the association will wait for “about a month” for dues to be cleared.

Suspension of CGHS cashless services: Empanelled hospitals to take call today
Thu, Dec 19, 2019

Over 18 lakh beneficiaries across the country used services under ECHS in 2018-19, shows government data.

‘Bioabsorbable’ stent: NPPA defers price cap exemption decision, cites ‘discrepant’ documents
Tue, Dec 17, 2019

According to the regulator, the firm has submitted a patent document for a ‘bioabsorbable’ stent, but its licence from the Drug Controller General of India (DCGI) was for a ‘bioresorbable’ stent.

In a first, regulator hikes prices of essential medicines
Sat, Dec 14, 2019

This is the first time the National Pharmaceutical Pricing Authority (NPPA) — which is known to slash prices of essential and life-saving medicines — is increasing prices in public interest.

Day after key diabetes drug goes off patent, 20 generics send prices down by up to 70%
Wed, Dec 11, 2019

Vildagliptin, which belongs to DPP-4 class of drugs, was launched in India in 2008 for treating type-2 diabetes.

Beyond trade margin caps, patient groups call for legal oversight of pharma marketing, promotion
Tue, Dec 10, 2019

The bodies have written to Minister of Chemicals and Fertilizers DV Sadananda Gowda, calling for a statutory code to prevent corruption and unethical marketing practices in these industries.

The dera by the Beas
Sun, Dec 08, 2019

The third figure in the Ranbaxy brothers’ corporate battle is Gurinder Singh Dhillon, the head of Radha Soami Satsang Beas — among the largest such communes in the world, with 20 mn followers in 90 countries, yet fiercely secretive. The Indian Express on the man and his sect

CDSCO flags drugs made by 3 PSUs for failing quality tests
Wed, Nov 27, 2019

At the same time, BCPL and HAL have disputed the claim that the samples were sub-standard, with BCPL also planning to challenge CDSCO’s findings.

Betnovate, Panderm samples fail quality tests; makers say products ‘counterfeited’
Mon, Nov 25, 2019

At the same time, the companies that market these products in India have said that the samples tested were counterfeited versions of their popular brands.

Trade margin cap on drugs, devices: Govt asks stakeholders for views on regulation
Sat, Nov 23, 2019

During a meeting held with various stakeholders on the issue, officials of the National Pharmaceutical Pricing Authority (NPPA) and the Department of Pharmaceuticals sought inputs on how much margins should be allowed for these products across the supply chain, said persons directly aware of the development.

133 units, switching off: Low demand behind half of thermal power plants shutting down
Sat, Nov 16, 2019

Of the country’s total installed generation capacity of 3,63,370 MW, the peak demand met was a little less than half at just around 1,88,072 MW on November 7, according to official data available with grid managers and analysed by The Indian Express.

Advertisement
Advertisement
Advertisement
Advertisement